Global Brigatinib API Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Brigatinib is an active pharmaceutical ingredient (API) used for the treatment of non-small cell lung cancer (NSCLC) with ALK gene mutations.It is a selective ALK inhibitor that works by blocking the ALK protein.
The global Brigatinib API market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Brigatinib API Industry Forecast” looks at past sales and reviews total world Brigatinib API sales in 2023, providing a comprehensive analysis by region and market sector of projected Brigatinib API sales for 2024 through 2030. With Brigatinib API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Brigatinib API industry.
This Insight Report provides a comprehensive analysis of the global Brigatinib API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Brigatinib API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Brigatinib API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Brigatinib API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Brigatinib API.
United States market for Brigatinib API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Brigatinib API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Brigatinib API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Brigatinib API players cover Dr. Reddy’s Laboratories, Vitasv Pharma And Chemical, LGC, Cayman Chemical, Conscientia Industrial, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Brigatinib API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Brigatinib API market?
What factors are driving Brigatinib API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Brigatinib API market opportunities vary by end market size?
How does Brigatinib API break out by Type, by Application?
Brigatinib is an active pharmaceutical ingredient (API) used for the treatment of non-small cell lung cancer (NSCLC) with ALK gene mutations.It is a selective ALK inhibitor that works by blocking the ALK protein.
The global Brigatinib API market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Brigatinib API Industry Forecast” looks at past sales and reviews total world Brigatinib API sales in 2023, providing a comprehensive analysis by region and market sector of projected Brigatinib API sales for 2024 through 2030. With Brigatinib API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Brigatinib API industry.
This Insight Report provides a comprehensive analysis of the global Brigatinib API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Brigatinib API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Brigatinib API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Brigatinib API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Brigatinib API.
United States market for Brigatinib API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Brigatinib API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Brigatinib API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Brigatinib API players cover Dr. Reddy’s Laboratories, Vitasv Pharma And Chemical, LGC, Cayman Chemical, Conscientia Industrial, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Brigatinib API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Purity?99%
- Purity<99%
- Online Sales
- Offline Sales
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Dr. Reddy’s Laboratories
- Vitasv Pharma And Chemical
- LGC
- Cayman Chemical
- Conscientia Industrial
- Manus Aktteva Biopharma LLP
- Selleck
- Shandong Sihuan Pharmaceutical
- Anqing benro Pharmaceutical
- Vasudha Pharma
- Hefei Home Sunshine Pharmaceutical Technology
- Sandoo Pharmaceuticals and Chemicals
What is the 10-year outlook for the global Brigatinib API market?
What factors are driving Brigatinib API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Brigatinib API market opportunities vary by end market size?
How does Brigatinib API break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Brigatinib API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Brigatinib API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Brigatinib API by Country/Region, 2019, 2023 & 2030
2.2 Brigatinib API Segment by Type
2.2.1 Purity?99%
2.2.2 Purity<99%
2.3 Brigatinib API Sales by Type
2.3.1 Global Brigatinib API Sales Market Share by Type (2019-2024)
2.3.2 Global Brigatinib API Revenue and Market Share by Type (2019-2024)
2.3.3 Global Brigatinib API Sale Price by Type (2019-2024)
2.4 Brigatinib API Segment by Application
2.4.1 Online Sales
2.4.2 Offline Sales
2.5 Brigatinib API Sales by Application
2.5.1 Global Brigatinib API Sale Market Share by Application (2019-2024)
2.5.2 Global Brigatinib API Revenue and Market Share by Application (2019-2024)
2.5.3 Global Brigatinib API Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Brigatinib API Breakdown Data by Company
3.1.1 Global Brigatinib API Annual Sales by Company (2019-2024)
3.1.2 Global Brigatinib API Sales Market Share by Company (2019-2024)
3.2 Global Brigatinib API Annual Revenue by Company (2019-2024)
3.2.1 Global Brigatinib API Revenue by Company (2019-2024)
3.2.2 Global Brigatinib API Revenue Market Share by Company (2019-2024)
3.3 Global Brigatinib API Sale Price by Company
3.4 Key Manufacturers Brigatinib API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Brigatinib API Product Location Distribution
3.4.2 Players Brigatinib API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BRIGATINIB API BY GEOGRAPHIC REGION
4.1 World Historic Brigatinib API Market Size by Geographic Region (2019-2024)
4.1.1 Global Brigatinib API Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Brigatinib API Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Brigatinib API Market Size by Country/Region (2019-2024)
4.2.1 Global Brigatinib API Annual Sales by Country/Region (2019-2024)
4.2.2 Global Brigatinib API Annual Revenue by Country/Region (2019-2024)
4.3 Americas Brigatinib API Sales Growth
4.4 APAC Brigatinib API Sales Growth
4.5 Europe Brigatinib API Sales Growth
4.6 Middle East & Africa Brigatinib API Sales Growth
5 AMERICAS
5.1 Americas Brigatinib API Sales by Country
5.1.1 Americas Brigatinib API Sales by Country (2019-2024)
5.1.2 Americas Brigatinib API Revenue by Country (2019-2024)
5.2 Americas Brigatinib API Sales by Type (2019-2024)
5.3 Americas Brigatinib API Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Brigatinib API Sales by Region
6.1.1 APAC Brigatinib API Sales by Region (2019-2024)
6.1.2 APAC Brigatinib API Revenue by Region (2019-2024)
6.2 APAC Brigatinib API Sales by Type (2019-2024)
6.3 APAC Brigatinib API Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Brigatinib API by Country
7.1.1 Europe Brigatinib API Sales by Country (2019-2024)
7.1.2 Europe Brigatinib API Revenue by Country (2019-2024)
7.2 Europe Brigatinib API Sales by Type (2019-2024)
7.3 Europe Brigatinib API Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Brigatinib API by Country
8.1.1 Middle East & Africa Brigatinib API Sales by Country (2019-2024)
8.1.2 Middle East & Africa Brigatinib API Revenue by Country (2019-2024)
8.2 Middle East & Africa Brigatinib API Sales by Type (2019-2024)
8.3 Middle East & Africa Brigatinib API Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Brigatinib API
10.3 Manufacturing Process Analysis of Brigatinib API
10.4 Industry Chain Structure of Brigatinib API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Brigatinib API Distributors
11.3 Brigatinib API Customer
12 WORLD FORECAST REVIEW FOR BRIGATINIB API BY GEOGRAPHIC REGION
12.1 Global Brigatinib API Market Size Forecast by Region
12.1.1 Global Brigatinib API Forecast by Region (2025-2030)
12.1.2 Global Brigatinib API Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Brigatinib API Forecast by Type (2025-2030)
12.7 Global Brigatinib API Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Dr. Reddy’s Laboratories
13.1.1 Dr. Reddy’s Laboratories Company Information
13.1.2 Dr. Reddy’s Laboratories Brigatinib API Product Portfolios and Specifications
13.1.3 Dr. Reddy’s Laboratories Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Dr. Reddy’s Laboratories Main Business Overview
13.1.5 Dr. Reddy’s Laboratories Latest Developments
13.2 Vitasv Pharma And Chemical
13.2.1 Vitasv Pharma And Chemical Company Information
13.2.2 Vitasv Pharma And Chemical Brigatinib API Product Portfolios and Specifications
13.2.3 Vitasv Pharma And Chemical Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Vitasv Pharma And Chemical Main Business Overview
13.2.5 Vitasv Pharma And Chemical Latest Developments
13.3 LGC
13.3.1 LGC Company Information
13.3.2 LGC Brigatinib API Product Portfolios and Specifications
13.3.3 LGC Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 LGC Main Business Overview
13.3.5 LGC Latest Developments
13.4 Cayman Chemical
13.4.1 Cayman Chemical Company Information
13.4.2 Cayman Chemical Brigatinib API Product Portfolios and Specifications
13.4.3 Cayman Chemical Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Cayman Chemical Main Business Overview
13.4.5 Cayman Chemical Latest Developments
13.5 Conscientia Industrial
13.5.1 Conscientia Industrial Company Information
13.5.2 Conscientia Industrial Brigatinib API Product Portfolios and Specifications
13.5.3 Conscientia Industrial Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Conscientia Industrial Main Business Overview
13.5.5 Conscientia Industrial Latest Developments
13.6 Manus Aktteva Biopharma LLP
13.6.1 Manus Aktteva Biopharma LLP Company Information
13.6.2 Manus Aktteva Biopharma LLP Brigatinib API Product Portfolios and Specifications
13.6.3 Manus Aktteva Biopharma LLP Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Manus Aktteva Biopharma LLP Main Business Overview
13.6.5 Manus Aktteva Biopharma LLP Latest Developments
13.7 Selleck
13.7.1 Selleck Company Information
13.7.2 Selleck Brigatinib API Product Portfolios and Specifications
13.7.3 Selleck Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Selleck Main Business Overview
13.7.5 Selleck Latest Developments
13.8 Shandong Sihuan Pharmaceutical
13.8.1 Shandong Sihuan Pharmaceutical Company Information
13.8.2 Shandong Sihuan Pharmaceutical Brigatinib API Product Portfolios and Specifications
13.8.3 Shandong Sihuan Pharmaceutical Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Shandong Sihuan Pharmaceutical Main Business Overview
13.8.5 Shandong Sihuan Pharmaceutical Latest Developments
13.9 Anqing benro Pharmaceutical
13.9.1 Anqing benro Pharmaceutical Company Information
13.9.2 Anqing benro Pharmaceutical Brigatinib API Product Portfolios and Specifications
13.9.3 Anqing benro Pharmaceutical Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Anqing benro Pharmaceutical Main Business Overview
13.9.5 Anqing benro Pharmaceutical Latest Developments
13.10 Vasudha Pharma
13.10.1 Vasudha Pharma Company Information
13.10.2 Vasudha Pharma Brigatinib API Product Portfolios and Specifications
13.10.3 Vasudha Pharma Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Vasudha Pharma Main Business Overview
13.10.5 Vasudha Pharma Latest Developments
13.11 Hefei Home Sunshine Pharmaceutical Technology
13.11.1 Hefei Home Sunshine Pharmaceutical Technology Company Information
13.11.2 Hefei Home Sunshine Pharmaceutical Technology Brigatinib API Product Portfolios and Specifications
13.11.3 Hefei Home Sunshine Pharmaceutical Technology Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hefei Home Sunshine Pharmaceutical Technology Main Business Overview
13.11.5 Hefei Home Sunshine Pharmaceutical Technology Latest Developments
13.12 Sandoo Pharmaceuticals and Chemicals
13.12.1 Sandoo Pharmaceuticals and Chemicals Company Information
13.12.2 Sandoo Pharmaceuticals and Chemicals Brigatinib API Product Portfolios and Specifications
13.12.3 Sandoo Pharmaceuticals and Chemicals Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Sandoo Pharmaceuticals and Chemicals Main Business Overview
13.12.5 Sandoo Pharmaceuticals and Chemicals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Brigatinib API Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Brigatinib API Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Purity?99%
Table 4. Major Players of Purity<99%
Table 5. Global Brigatinib API Sales byType (2019-2024) & (kg)
Table 6. Global Brigatinib API Sales Market Share byType (2019-2024)
Table 7. Global Brigatinib API Revenue byType (2019-2024) & ($ million)
Table 8. Global Brigatinib API Revenue Market Share byType (2019-2024)
Table 9. Global Brigatinib API Sale Price byType (2019-2024) & (US$/kg)
Table 10. Global Brigatinib API Sale by Application (2019-2024) & (kg)
Table 11. Global Brigatinib API Sale Market Share by Application (2019-2024)
Table 12. Global Brigatinib API Revenue by Application (2019-2024) & ($ million)
Table 13. Global Brigatinib API Revenue Market Share by Application (2019-2024)
Table 14. Global Brigatinib API Sale Price by Application (2019-2024) & (US$/kg)
Table 15. Global Brigatinib API Sales by Company (2019-2024) & (kg)
Table 16. Global Brigatinib API Sales Market Share by Company (2019-2024)
Table 17. Global Brigatinib API Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Brigatinib API Revenue Market Share by Company (2019-2024)
Table 19. Global Brigatinib API Sale Price by Company (2019-2024) & (US$/kg)
Table 20. Key Manufacturers Brigatinib API Producing Area Distribution and Sales Area
Table 21. Players Brigatinib API Products Offered
Table 22. Brigatinib API Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Brigatinib API Sales by Geographic Region (2019-2024) & (kg)
Table 26. Global Brigatinib API Sales Market Share Geographic Region (2019-2024)
Table 27. Global Brigatinib API Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Brigatinib API Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Brigatinib API Sales by Country/Region (2019-2024) & (kg)
Table 30. Global Brigatinib API Sales Market Share by Country/Region (2019-2024)
Table 31. Global Brigatinib API Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Brigatinib API Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Brigatinib API Sales by Country (2019-2024) & (kg)
Table 34. Americas Brigatinib API Sales Market Share by Country (2019-2024)
Table 35. Americas Brigatinib API Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Brigatinib API Sales byType (2019-2024) & (kg)
Table 37. Americas Brigatinib API Sales by Application (2019-2024) & (kg)
Table 38. APAC Brigatinib API Sales by Region (2019-2024) & (kg)
Table 39. APAC Brigatinib API Sales Market Share by Region (2019-2024)
Table 40. APAC Brigatinib API Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Brigatinib API Sales byType (2019-2024) & (kg)
Table 42. APAC Brigatinib API Sales by Application (2019-2024) & (kg)
Table 43. Europe Brigatinib API Sales by Country (2019-2024) & (kg)
Table 44. Europe Brigatinib API Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Brigatinib API Sales byType (2019-2024) & (kg)
Table 46. Europe Brigatinib API Sales by Application (2019-2024) & (kg)
Table 47. Middle East & Africa Brigatinib API Sales by Country (2019-2024) & (kg)
Table 48. Middle East & Africa Brigatinib API Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Brigatinib API Sales byType (2019-2024) & (kg)
Table 50. Middle East & Africa Brigatinib API Sales by Application (2019-2024) & (kg)
Table 51. Key Market Drivers & Growth Opportunities of Brigatinib API
Table 52. Key Market Challenges & Risks of Brigatinib API
Table 53. Key IndustryTrends of Brigatinib API
Table 54. Brigatinib API Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Brigatinib API Distributors List
Table 57. Brigatinib API Customer List
Table 58. Global Brigatinib API SalesForecast by Region (2025-2030) & (kg)
Table 59. Global Brigatinib API RevenueForecast by Region (2025-2030) & ($ millions)
Table 60. Americas Brigatinib API SalesForecast by Country (2025-2030) & (kg)
Table 61. Americas Brigatinib API Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 62. APAC Brigatinib API SalesForecast by Region (2025-2030) & (kg)
Table 63. APAC Brigatinib API Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. Europe Brigatinib API SalesForecast by Country (2025-2030) & (kg)
Table 65. Europe Brigatinib API RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Brigatinib API SalesForecast by Country (2025-2030) & (kg)
Table 67. Middle East & Africa Brigatinib API RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. Global Brigatinib API SalesForecast byType (2025-2030) & (kg)
Table 69. Global Brigatinib API RevenueForecast byType (2025-2030) & ($ millions)
Table 70. Global Brigatinib API SalesForecast by Application (2025-2030) & (kg)
Table 71. Global Brigatinib API RevenueForecast by Application (2025-2030) & ($ millions)
Table 72. Dr. Reddy’s Laboratories Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 73. Dr. Reddy’s Laboratories Brigatinib API Product Portfolios and Specifications
Table 74. Dr. Reddy’s Laboratories Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 75. Dr. Reddy’s Laboratories Main Business
Table 76. Dr. Reddy’s Laboratories Latest Developments
Table 77. Vitasv Pharma And Chemical Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 78. Vitasv Pharma And Chemical Brigatinib API Product Portfolios and Specifications
Table 79. Vitasv Pharma And Chemical Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 80. Vitasv Pharma And Chemical Main Business
Table 81. Vitasv Pharma And Chemical Latest Developments
Table 82. LGC Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 83. LGC Brigatinib API Product Portfolios and Specifications
Table 84. LGC Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 85. LGC Main Business
Table 86. LGC Latest Developments
Table 87. Cayman Chemical Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 88. Cayman Chemical Brigatinib API Product Portfolios and Specifications
Table 89. Cayman Chemical Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 90. Cayman Chemical Main Business
Table 91. Cayman Chemical Latest Developments
Table 92. Conscientia Industrial Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 93. Conscientia Industrial Brigatinib API Product Portfolios and Specifications
Table 94. Conscientia Industrial Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 95. Conscientia Industrial Main Business
Table 96. Conscientia Industrial Latest Developments
Table 97. Manus Aktteva Biopharma LLP Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 98. Manus Aktteva Biopharma LLP Brigatinib API Product Portfolios and Specifications
Table 99. Manus Aktteva Biopharma LLP Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 100. Manus Aktteva Biopharma LLP Main Business
Table 101. Manus Aktteva Biopharma LLP Latest Developments
Table 102. Selleck Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 103. Selleck Brigatinib API Product Portfolios and Specifications
Table 104. Selleck Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 105. Selleck Main Business
Table 106. Selleck Latest Developments
Table 107. Shandong Sihuan Pharmaceutical Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 108. Shandong Sihuan Pharmaceutical Brigatinib API Product Portfolios and Specifications
Table 109. Shandong Sihuan Pharmaceutical Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 110. Shandong Sihuan Pharmaceutical Main Business
Table 111. Shandong Sihuan Pharmaceutical Latest Developments
Table 112. Anqing benro Pharmaceutical Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 113. Anqing benro Pharmaceutical Brigatinib API Product Portfolios and Specifications
Table 114. Anqing benro Pharmaceutical Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 115. Anqing benro Pharmaceutical Main Business
Table 116. Anqing benro Pharmaceutical Latest Developments
Table 117. Vasudha Pharma Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 118. Vasudha Pharma Brigatinib API Product Portfolios and Specifications
Table 119. Vasudha Pharma Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 120. Vasudha Pharma Main Business
Table 121. Vasudha Pharma Latest Developments
Table 122. Hefei Home Sunshine PharmaceuticalTechnology Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 123. Hefei Home Sunshine PharmaceuticalTechnology Brigatinib API Product Portfolios and Specifications
Table 124. Hefei Home Sunshine PharmaceuticalTechnology Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 125. Hefei Home Sunshine PharmaceuticalTechnology Main Business
Table 126. Hefei Home Sunshine PharmaceuticalTechnology Latest Developments
Table 127. Sandoo Pharmaceuticals and Chemicals Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 128. Sandoo Pharmaceuticals and Chemicals Brigatinib API Product Portfolios and Specifications
Table 129. Sandoo Pharmaceuticals and Chemicals Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 130. Sandoo Pharmaceuticals and Chemicals Main Business
Table 131. Sandoo Pharmaceuticals and Chemicals Latest Developments
LIST OFFIGURES
Figure 1. Picture of Brigatinib API
Figure 2. Brigatinib API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Brigatinib API Sales Growth Rate 2019-2030 (kg)
Figure 7. Global Brigatinib API Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Brigatinib API Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Brigatinib API Sales Market Share by Country/Region (2023)
Figure 10. Brigatinib API Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Purity?99%
Figure 12. Product Picture of Purity<99%
Figure 13. Global Brigatinib API Sales Market Share byType in 2023
Figure 14. Global Brigatinib API Revenue Market Share byType (2019-2024)
Figure 15. Brigatinib API Consumed in Online Sales
Figure 16. Global Brigatinib API Market: Online Sales (2019-2024) & (kg)
Figure 17. Brigatinib API Consumed in Offline Sales
Figure 18. Global Brigatinib API Market: Offline Sales (2019-2024) & (kg)
Figure 19. Global Brigatinib API Sale Market Share by Application (2023)
Figure 20. Global Brigatinib API Revenue Market Share by Application in 2023
Figure 21. Brigatinib API Sales by Company in 2023 (kg)
Figure 22. Global Brigatinib API Sales Market Share by Company in 2023
Figure 23. Brigatinib API Revenue by Company in 2023 ($ millions)
Figure 24. Global Brigatinib API Revenue Market Share by Company in 2023
Figure 25. Global Brigatinib API Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Brigatinib API Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Brigatinib API Sales 2019-2024 (kg)
Figure 28. Americas Brigatinib API Revenue 2019-2024 ($ millions)
Figure 29. APAC Brigatinib API Sales 2019-2024 (kg)
Figure 30. APAC Brigatinib API Revenue 2019-2024 ($ millions)
Figure 31. Europe Brigatinib API Sales 2019-2024 (kg)
Figure 32. Europe Brigatinib API Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa Brigatinib API Sales 2019-2024 (kg)
Figure 34. Middle East & Africa Brigatinib API Revenue 2019-2024 ($ millions)
Figure 35. Americas Brigatinib API Sales Market Share by Country in 2023
Figure 36. Americas Brigatinib API Revenue Market Share by Country (2019-2024)
Figure 37. Americas Brigatinib API Sales Market Share byType (2019-2024)
Figure 38. Americas Brigatinib API Sales Market Share by Application (2019-2024)
Figure 39. United States Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC Brigatinib API Sales Market Share by Region in 2023
Figure 44. APAC Brigatinib API Revenue Market Share by Region (2019-2024)
Figure 45. APAC Brigatinib API Sales Market Share byType (2019-2024)
Figure 46. APAC Brigatinib API Sales Market Share by Application (2019-2024)
Figure 47. China Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 51. India Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 53. ChinaTaiwan Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe Brigatinib API Sales Market Share by Country in 2023
Figure 55. Europe Brigatinib API Revenue Market Share by Country (2019-2024)
Figure 56. Europe Brigatinib API Sales Market Share byType (2019-2024)
Figure 57. Europe Brigatinib API Sales Market Share by Application (2019-2024)
Figure 58. Germany Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 59.France Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 60. UK Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa Brigatinib API Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa Brigatinib API Sales Market Share byType (2019-2024)
Figure 65. Middle East & Africa Brigatinib API Sales Market Share by Application (2019-2024)
Figure 66. Egypt Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 69.Turkey Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Brigatinib API in 2023
Figure 72. Manufacturing Process Analysis of Brigatinib API
Figure 73. Industry Chain Structure of Brigatinib API
Figure 74. Channels of Distribution
Figure 75. Global Brigatinib API Sales MarketForecast by Region (2025-2030)
Figure 76. Global Brigatinib API Revenue Market ShareForecast by Region (2025-2030)
Figure 77. Global Brigatinib API Sales Market ShareForecast byType (2025-2030)
Figure 78. Global Brigatinib API Revenue Market ShareForecast byType (2025-2030)
Figure 79. Global Brigatinib API Sales Market ShareForecast by Application (2025-2030)
Figure 80. Global Brigatinib API Revenue Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Brigatinib API Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Brigatinib API by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Brigatinib API by Country/Region, 2019, 2023 & 2030
2.2 Brigatinib API Segment by Type
2.2.1 Purity?99%
2.2.2 Purity<99%
2.3 Brigatinib API Sales by Type
2.3.1 Global Brigatinib API Sales Market Share by Type (2019-2024)
2.3.2 Global Brigatinib API Revenue and Market Share by Type (2019-2024)
2.3.3 Global Brigatinib API Sale Price by Type (2019-2024)
2.4 Brigatinib API Segment by Application
2.4.1 Online Sales
2.4.2 Offline Sales
2.5 Brigatinib API Sales by Application
2.5.1 Global Brigatinib API Sale Market Share by Application (2019-2024)
2.5.2 Global Brigatinib API Revenue and Market Share by Application (2019-2024)
2.5.3 Global Brigatinib API Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Brigatinib API Breakdown Data by Company
3.1.1 Global Brigatinib API Annual Sales by Company (2019-2024)
3.1.2 Global Brigatinib API Sales Market Share by Company (2019-2024)
3.2 Global Brigatinib API Annual Revenue by Company (2019-2024)
3.2.1 Global Brigatinib API Revenue by Company (2019-2024)
3.2.2 Global Brigatinib API Revenue Market Share by Company (2019-2024)
3.3 Global Brigatinib API Sale Price by Company
3.4 Key Manufacturers Brigatinib API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Brigatinib API Product Location Distribution
3.4.2 Players Brigatinib API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BRIGATINIB API BY GEOGRAPHIC REGION
4.1 World Historic Brigatinib API Market Size by Geographic Region (2019-2024)
4.1.1 Global Brigatinib API Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Brigatinib API Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Brigatinib API Market Size by Country/Region (2019-2024)
4.2.1 Global Brigatinib API Annual Sales by Country/Region (2019-2024)
4.2.2 Global Brigatinib API Annual Revenue by Country/Region (2019-2024)
4.3 Americas Brigatinib API Sales Growth
4.4 APAC Brigatinib API Sales Growth
4.5 Europe Brigatinib API Sales Growth
4.6 Middle East & Africa Brigatinib API Sales Growth
5 AMERICAS
5.1 Americas Brigatinib API Sales by Country
5.1.1 Americas Brigatinib API Sales by Country (2019-2024)
5.1.2 Americas Brigatinib API Revenue by Country (2019-2024)
5.2 Americas Brigatinib API Sales by Type (2019-2024)
5.3 Americas Brigatinib API Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Brigatinib API Sales by Region
6.1.1 APAC Brigatinib API Sales by Region (2019-2024)
6.1.2 APAC Brigatinib API Revenue by Region (2019-2024)
6.2 APAC Brigatinib API Sales by Type (2019-2024)
6.3 APAC Brigatinib API Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Brigatinib API by Country
7.1.1 Europe Brigatinib API Sales by Country (2019-2024)
7.1.2 Europe Brigatinib API Revenue by Country (2019-2024)
7.2 Europe Brigatinib API Sales by Type (2019-2024)
7.3 Europe Brigatinib API Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Brigatinib API by Country
8.1.1 Middle East & Africa Brigatinib API Sales by Country (2019-2024)
8.1.2 Middle East & Africa Brigatinib API Revenue by Country (2019-2024)
8.2 Middle East & Africa Brigatinib API Sales by Type (2019-2024)
8.3 Middle East & Africa Brigatinib API Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Brigatinib API
10.3 Manufacturing Process Analysis of Brigatinib API
10.4 Industry Chain Structure of Brigatinib API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Brigatinib API Distributors
11.3 Brigatinib API Customer
12 WORLD FORECAST REVIEW FOR BRIGATINIB API BY GEOGRAPHIC REGION
12.1 Global Brigatinib API Market Size Forecast by Region
12.1.1 Global Brigatinib API Forecast by Region (2025-2030)
12.1.2 Global Brigatinib API Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Brigatinib API Forecast by Type (2025-2030)
12.7 Global Brigatinib API Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Dr. Reddy’s Laboratories
13.1.1 Dr. Reddy’s Laboratories Company Information
13.1.2 Dr. Reddy’s Laboratories Brigatinib API Product Portfolios and Specifications
13.1.3 Dr. Reddy’s Laboratories Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Dr. Reddy’s Laboratories Main Business Overview
13.1.5 Dr. Reddy’s Laboratories Latest Developments
13.2 Vitasv Pharma And Chemical
13.2.1 Vitasv Pharma And Chemical Company Information
13.2.2 Vitasv Pharma And Chemical Brigatinib API Product Portfolios and Specifications
13.2.3 Vitasv Pharma And Chemical Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Vitasv Pharma And Chemical Main Business Overview
13.2.5 Vitasv Pharma And Chemical Latest Developments
13.3 LGC
13.3.1 LGC Company Information
13.3.2 LGC Brigatinib API Product Portfolios and Specifications
13.3.3 LGC Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 LGC Main Business Overview
13.3.5 LGC Latest Developments
13.4 Cayman Chemical
13.4.1 Cayman Chemical Company Information
13.4.2 Cayman Chemical Brigatinib API Product Portfolios and Specifications
13.4.3 Cayman Chemical Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Cayman Chemical Main Business Overview
13.4.5 Cayman Chemical Latest Developments
13.5 Conscientia Industrial
13.5.1 Conscientia Industrial Company Information
13.5.2 Conscientia Industrial Brigatinib API Product Portfolios and Specifications
13.5.3 Conscientia Industrial Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Conscientia Industrial Main Business Overview
13.5.5 Conscientia Industrial Latest Developments
13.6 Manus Aktteva Biopharma LLP
13.6.1 Manus Aktteva Biopharma LLP Company Information
13.6.2 Manus Aktteva Biopharma LLP Brigatinib API Product Portfolios and Specifications
13.6.3 Manus Aktteva Biopharma LLP Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Manus Aktteva Biopharma LLP Main Business Overview
13.6.5 Manus Aktteva Biopharma LLP Latest Developments
13.7 Selleck
13.7.1 Selleck Company Information
13.7.2 Selleck Brigatinib API Product Portfolios and Specifications
13.7.3 Selleck Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Selleck Main Business Overview
13.7.5 Selleck Latest Developments
13.8 Shandong Sihuan Pharmaceutical
13.8.1 Shandong Sihuan Pharmaceutical Company Information
13.8.2 Shandong Sihuan Pharmaceutical Brigatinib API Product Portfolios and Specifications
13.8.3 Shandong Sihuan Pharmaceutical Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Shandong Sihuan Pharmaceutical Main Business Overview
13.8.5 Shandong Sihuan Pharmaceutical Latest Developments
13.9 Anqing benro Pharmaceutical
13.9.1 Anqing benro Pharmaceutical Company Information
13.9.2 Anqing benro Pharmaceutical Brigatinib API Product Portfolios and Specifications
13.9.3 Anqing benro Pharmaceutical Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Anqing benro Pharmaceutical Main Business Overview
13.9.5 Anqing benro Pharmaceutical Latest Developments
13.10 Vasudha Pharma
13.10.1 Vasudha Pharma Company Information
13.10.2 Vasudha Pharma Brigatinib API Product Portfolios and Specifications
13.10.3 Vasudha Pharma Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Vasudha Pharma Main Business Overview
13.10.5 Vasudha Pharma Latest Developments
13.11 Hefei Home Sunshine Pharmaceutical Technology
13.11.1 Hefei Home Sunshine Pharmaceutical Technology Company Information
13.11.2 Hefei Home Sunshine Pharmaceutical Technology Brigatinib API Product Portfolios and Specifications
13.11.3 Hefei Home Sunshine Pharmaceutical Technology Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hefei Home Sunshine Pharmaceutical Technology Main Business Overview
13.11.5 Hefei Home Sunshine Pharmaceutical Technology Latest Developments
13.12 Sandoo Pharmaceuticals and Chemicals
13.12.1 Sandoo Pharmaceuticals and Chemicals Company Information
13.12.2 Sandoo Pharmaceuticals and Chemicals Brigatinib API Product Portfolios and Specifications
13.12.3 Sandoo Pharmaceuticals and Chemicals Brigatinib API Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Sandoo Pharmaceuticals and Chemicals Main Business Overview
13.12.5 Sandoo Pharmaceuticals and Chemicals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Brigatinib API Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Brigatinib API Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Purity?99%
Table 4. Major Players of Purity<99%
Table 5. Global Brigatinib API Sales byType (2019-2024) & (kg)
Table 6. Global Brigatinib API Sales Market Share byType (2019-2024)
Table 7. Global Brigatinib API Revenue byType (2019-2024) & ($ million)
Table 8. Global Brigatinib API Revenue Market Share byType (2019-2024)
Table 9. Global Brigatinib API Sale Price byType (2019-2024) & (US$/kg)
Table 10. Global Brigatinib API Sale by Application (2019-2024) & (kg)
Table 11. Global Brigatinib API Sale Market Share by Application (2019-2024)
Table 12. Global Brigatinib API Revenue by Application (2019-2024) & ($ million)
Table 13. Global Brigatinib API Revenue Market Share by Application (2019-2024)
Table 14. Global Brigatinib API Sale Price by Application (2019-2024) & (US$/kg)
Table 15. Global Brigatinib API Sales by Company (2019-2024) & (kg)
Table 16. Global Brigatinib API Sales Market Share by Company (2019-2024)
Table 17. Global Brigatinib API Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Brigatinib API Revenue Market Share by Company (2019-2024)
Table 19. Global Brigatinib API Sale Price by Company (2019-2024) & (US$/kg)
Table 20. Key Manufacturers Brigatinib API Producing Area Distribution and Sales Area
Table 21. Players Brigatinib API Products Offered
Table 22. Brigatinib API Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Brigatinib API Sales by Geographic Region (2019-2024) & (kg)
Table 26. Global Brigatinib API Sales Market Share Geographic Region (2019-2024)
Table 27. Global Brigatinib API Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Brigatinib API Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Brigatinib API Sales by Country/Region (2019-2024) & (kg)
Table 30. Global Brigatinib API Sales Market Share by Country/Region (2019-2024)
Table 31. Global Brigatinib API Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Brigatinib API Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Brigatinib API Sales by Country (2019-2024) & (kg)
Table 34. Americas Brigatinib API Sales Market Share by Country (2019-2024)
Table 35. Americas Brigatinib API Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Brigatinib API Sales byType (2019-2024) & (kg)
Table 37. Americas Brigatinib API Sales by Application (2019-2024) & (kg)
Table 38. APAC Brigatinib API Sales by Region (2019-2024) & (kg)
Table 39. APAC Brigatinib API Sales Market Share by Region (2019-2024)
Table 40. APAC Brigatinib API Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Brigatinib API Sales byType (2019-2024) & (kg)
Table 42. APAC Brigatinib API Sales by Application (2019-2024) & (kg)
Table 43. Europe Brigatinib API Sales by Country (2019-2024) & (kg)
Table 44. Europe Brigatinib API Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Brigatinib API Sales byType (2019-2024) & (kg)
Table 46. Europe Brigatinib API Sales by Application (2019-2024) & (kg)
Table 47. Middle East & Africa Brigatinib API Sales by Country (2019-2024) & (kg)
Table 48. Middle East & Africa Brigatinib API Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Brigatinib API Sales byType (2019-2024) & (kg)
Table 50. Middle East & Africa Brigatinib API Sales by Application (2019-2024) & (kg)
Table 51. Key Market Drivers & Growth Opportunities of Brigatinib API
Table 52. Key Market Challenges & Risks of Brigatinib API
Table 53. Key IndustryTrends of Brigatinib API
Table 54. Brigatinib API Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Brigatinib API Distributors List
Table 57. Brigatinib API Customer List
Table 58. Global Brigatinib API SalesForecast by Region (2025-2030) & (kg)
Table 59. Global Brigatinib API RevenueForecast by Region (2025-2030) & ($ millions)
Table 60. Americas Brigatinib API SalesForecast by Country (2025-2030) & (kg)
Table 61. Americas Brigatinib API Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 62. APAC Brigatinib API SalesForecast by Region (2025-2030) & (kg)
Table 63. APAC Brigatinib API Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. Europe Brigatinib API SalesForecast by Country (2025-2030) & (kg)
Table 65. Europe Brigatinib API RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Brigatinib API SalesForecast by Country (2025-2030) & (kg)
Table 67. Middle East & Africa Brigatinib API RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. Global Brigatinib API SalesForecast byType (2025-2030) & (kg)
Table 69. Global Brigatinib API RevenueForecast byType (2025-2030) & ($ millions)
Table 70. Global Brigatinib API SalesForecast by Application (2025-2030) & (kg)
Table 71. Global Brigatinib API RevenueForecast by Application (2025-2030) & ($ millions)
Table 72. Dr. Reddy’s Laboratories Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 73. Dr. Reddy’s Laboratories Brigatinib API Product Portfolios and Specifications
Table 74. Dr. Reddy’s Laboratories Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 75. Dr. Reddy’s Laboratories Main Business
Table 76. Dr. Reddy’s Laboratories Latest Developments
Table 77. Vitasv Pharma And Chemical Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 78. Vitasv Pharma And Chemical Brigatinib API Product Portfolios and Specifications
Table 79. Vitasv Pharma And Chemical Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 80. Vitasv Pharma And Chemical Main Business
Table 81. Vitasv Pharma And Chemical Latest Developments
Table 82. LGC Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 83. LGC Brigatinib API Product Portfolios and Specifications
Table 84. LGC Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 85. LGC Main Business
Table 86. LGC Latest Developments
Table 87. Cayman Chemical Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 88. Cayman Chemical Brigatinib API Product Portfolios and Specifications
Table 89. Cayman Chemical Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 90. Cayman Chemical Main Business
Table 91. Cayman Chemical Latest Developments
Table 92. Conscientia Industrial Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 93. Conscientia Industrial Brigatinib API Product Portfolios and Specifications
Table 94. Conscientia Industrial Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 95. Conscientia Industrial Main Business
Table 96. Conscientia Industrial Latest Developments
Table 97. Manus Aktteva Biopharma LLP Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 98. Manus Aktteva Biopharma LLP Brigatinib API Product Portfolios and Specifications
Table 99. Manus Aktteva Biopharma LLP Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 100. Manus Aktteva Biopharma LLP Main Business
Table 101. Manus Aktteva Biopharma LLP Latest Developments
Table 102. Selleck Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 103. Selleck Brigatinib API Product Portfolios and Specifications
Table 104. Selleck Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 105. Selleck Main Business
Table 106. Selleck Latest Developments
Table 107. Shandong Sihuan Pharmaceutical Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 108. Shandong Sihuan Pharmaceutical Brigatinib API Product Portfolios and Specifications
Table 109. Shandong Sihuan Pharmaceutical Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 110. Shandong Sihuan Pharmaceutical Main Business
Table 111. Shandong Sihuan Pharmaceutical Latest Developments
Table 112. Anqing benro Pharmaceutical Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 113. Anqing benro Pharmaceutical Brigatinib API Product Portfolios and Specifications
Table 114. Anqing benro Pharmaceutical Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 115. Anqing benro Pharmaceutical Main Business
Table 116. Anqing benro Pharmaceutical Latest Developments
Table 117. Vasudha Pharma Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 118. Vasudha Pharma Brigatinib API Product Portfolios and Specifications
Table 119. Vasudha Pharma Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 120. Vasudha Pharma Main Business
Table 121. Vasudha Pharma Latest Developments
Table 122. Hefei Home Sunshine PharmaceuticalTechnology Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 123. Hefei Home Sunshine PharmaceuticalTechnology Brigatinib API Product Portfolios and Specifications
Table 124. Hefei Home Sunshine PharmaceuticalTechnology Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 125. Hefei Home Sunshine PharmaceuticalTechnology Main Business
Table 126. Hefei Home Sunshine PharmaceuticalTechnology Latest Developments
Table 127. Sandoo Pharmaceuticals and Chemicals Basic Information, Brigatinib API Manufacturing Base, Sales Area and Its Competitors
Table 128. Sandoo Pharmaceuticals and Chemicals Brigatinib API Product Portfolios and Specifications
Table 129. Sandoo Pharmaceuticals and Chemicals Brigatinib API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 130. Sandoo Pharmaceuticals and Chemicals Main Business
Table 131. Sandoo Pharmaceuticals and Chemicals Latest Developments
LIST OFFIGURES
Figure 1. Picture of Brigatinib API
Figure 2. Brigatinib API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Brigatinib API Sales Growth Rate 2019-2030 (kg)
Figure 7. Global Brigatinib API Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Brigatinib API Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Brigatinib API Sales Market Share by Country/Region (2023)
Figure 10. Brigatinib API Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Purity?99%
Figure 12. Product Picture of Purity<99%
Figure 13. Global Brigatinib API Sales Market Share byType in 2023
Figure 14. Global Brigatinib API Revenue Market Share byType (2019-2024)
Figure 15. Brigatinib API Consumed in Online Sales
Figure 16. Global Brigatinib API Market: Online Sales (2019-2024) & (kg)
Figure 17. Brigatinib API Consumed in Offline Sales
Figure 18. Global Brigatinib API Market: Offline Sales (2019-2024) & (kg)
Figure 19. Global Brigatinib API Sale Market Share by Application (2023)
Figure 20. Global Brigatinib API Revenue Market Share by Application in 2023
Figure 21. Brigatinib API Sales by Company in 2023 (kg)
Figure 22. Global Brigatinib API Sales Market Share by Company in 2023
Figure 23. Brigatinib API Revenue by Company in 2023 ($ millions)
Figure 24. Global Brigatinib API Revenue Market Share by Company in 2023
Figure 25. Global Brigatinib API Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Brigatinib API Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Brigatinib API Sales 2019-2024 (kg)
Figure 28. Americas Brigatinib API Revenue 2019-2024 ($ millions)
Figure 29. APAC Brigatinib API Sales 2019-2024 (kg)
Figure 30. APAC Brigatinib API Revenue 2019-2024 ($ millions)
Figure 31. Europe Brigatinib API Sales 2019-2024 (kg)
Figure 32. Europe Brigatinib API Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa Brigatinib API Sales 2019-2024 (kg)
Figure 34. Middle East & Africa Brigatinib API Revenue 2019-2024 ($ millions)
Figure 35. Americas Brigatinib API Sales Market Share by Country in 2023
Figure 36. Americas Brigatinib API Revenue Market Share by Country (2019-2024)
Figure 37. Americas Brigatinib API Sales Market Share byType (2019-2024)
Figure 38. Americas Brigatinib API Sales Market Share by Application (2019-2024)
Figure 39. United States Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC Brigatinib API Sales Market Share by Region in 2023
Figure 44. APAC Brigatinib API Revenue Market Share by Region (2019-2024)
Figure 45. APAC Brigatinib API Sales Market Share byType (2019-2024)
Figure 46. APAC Brigatinib API Sales Market Share by Application (2019-2024)
Figure 47. China Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 51. India Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 53. ChinaTaiwan Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe Brigatinib API Sales Market Share by Country in 2023
Figure 55. Europe Brigatinib API Revenue Market Share by Country (2019-2024)
Figure 56. Europe Brigatinib API Sales Market Share byType (2019-2024)
Figure 57. Europe Brigatinib API Sales Market Share by Application (2019-2024)
Figure 58. Germany Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 59.France Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 60. UK Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa Brigatinib API Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa Brigatinib API Sales Market Share byType (2019-2024)
Figure 65. Middle East & Africa Brigatinib API Sales Market Share by Application (2019-2024)
Figure 66. Egypt Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 69.Turkey Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries Brigatinib API Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Brigatinib API in 2023
Figure 72. Manufacturing Process Analysis of Brigatinib API
Figure 73. Industry Chain Structure of Brigatinib API
Figure 74. Channels of Distribution
Figure 75. Global Brigatinib API Sales MarketForecast by Region (2025-2030)
Figure 76. Global Brigatinib API Revenue Market ShareForecast by Region (2025-2030)
Figure 77. Global Brigatinib API Sales Market ShareForecast byType (2025-2030)
Figure 78. Global Brigatinib API Revenue Market ShareForecast byType (2025-2030)
Figure 79. Global Brigatinib API Sales Market ShareForecast by Application (2025-2030)
Figure 80. Global Brigatinib API Revenue Market ShareForecast by Application (2025-2030)
